BackAustralian Clinical Labs Limited Overview

Australian Clinical Labs Limited Common Stock

Latest common stock for ACL.AX: $760M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$758.94M
↓ 2.79% YoYΔ $-21.79M vs prior year quarter

Peer trimmed avg / median

Loading

Australian Clinical Labs Limited Common Stock History

Loading

Australian Clinical Labs Limited vs. peers: Common Stock Comparison

Loading

Australian Clinical Labs Limited Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Australian Clinical Labs Limited (ACL.AX) FAQ

Australian Clinical Labs Limited's common stock stands at $760M as of June 2026. That compares with $780M in the prior-year period — down 2.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Australian Clinical Labs Limited reported $760M in common stock versus $780M a year earlier — a 2.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $780M in the prior-year period — down 2.8% year over year. Sustained growth in common stock can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Australian Clinical Labs Limited's common stock evolved across reporting periods, while the comparison chart places ACL.AX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers